273 related articles for article (PubMed ID: 31480064)
21. Subgroup and subtype-specific outcomes in adult medulloblastoma.
Coltin H; Sundaresan L; Smith KS; Skowron P; Massimi L; Eberhart CG; Schreck KC; Gupta N; Weiss WA; Tirapelli D; Carlotti C; Li KKW; Ryzhova M; Golanov A; Zheludkova O; Absalyamova O; Okonechnikov K; Stichel D; von Deimling A; Giannini C; Raskin S; Van Meir EG; Chan JA; Fults D; Chambless LB; Kim SK; Vasiljevic A; Faure-Conter C; Vibhakar R; Jung S; Leary S; Mora J; McLendon RE; Pollack IF; Hauser P; Grajkowska WA; Rubin JB; van Veelen MC; French PJ; Kros JM; Liau LM; Pfister SM; Kool M; Kijima N; Taylor MD; Packer RJ; Northcott PA; Korshunov A; Ramaswamy V
Acta Neuropathol; 2021 Nov; 142(5):859-871. PubMed ID: 34409497
[TBL] [Abstract][Full Text] [Related]
22. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.
Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M
Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271
[TBL] [Abstract][Full Text] [Related]
24. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B
J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008
[TBL] [Abstract][Full Text] [Related]
25. MRI Radiogenomics of Pediatric Medulloblastoma: A Multicenter Study.
Zhang M; Wong SW; Wright JN; Wagner MW; Toescu S; Han M; Tam LT; Zhou Q; Ahmadian SS; Shpanskaya K; Lummus S; Lai H; Eghbal A; Radmanesh A; Nemelka J; Harward S; Malinzak M; Laughlin S; Perreault S; Braun KRM; Lober RM; Cho YJ; Ertl-Wagner B; Ho CY; Mankad K; Vogel H; Cheshier SH; Jacques TS; Aquilina K; Fisher PG; Taylor M; Poussaint T; Vitanza NA; Grant GA; Pfister S; Thompson E; Jaju A; Ramaswamy V; Yeom KW
Radiology; 2022 Aug; 304(2):406-416. PubMed ID: 35438562
[TBL] [Abstract][Full Text] [Related]
26. Craniospinal radiotherapy in adult medulloblastoma.
Selek U; Zorlu F; Hurmuz P; Cengiz M; Turker A; Soylemezoglu F; Gurkaynak M
Strahlenther Onkol; 2007 May; 183(5):236-40. PubMed ID: 17497094
[TBL] [Abstract][Full Text] [Related]
27. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
[TBL] [Abstract][Full Text] [Related]
28. Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.
Aras Y; Dölen D; İribas Çelik A; Kılıç G; Kebudi R; Ünverengil G; Sabancı PA; İzgi AN
Childs Nerv Syst; 2021 Dec; 37(12):3733-3742. PubMed ID: 34550414
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases.
Yu J; Zhao R; Shi W; Li H
Clinics (Sao Paulo); 2017 May; 72(5):294-304. PubMed ID: 28591342
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
32. Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.
Mynarek M; von Hoff K; Pietsch T; Ottensmeier H; Warmuth-Metz M; Bison B; Pfister S; Korshunov A; Sharma T; Jaeger N; Ryzhova M; Zheludkova O; Golanov A; Rushing EJ; Hasselblatt M; Koch A; Schüller U; von Deimling A; Sahm F; Sill M; Riemenschneider MJ; Dohmen H; Monoranu CM; Sommer C; Staszewski O; Mawrin C; Schittenhelm J; Brück W; Filipski K; Hartmann C; Meinhardt M; Pietschmann K; Haberler C; Slavc I; Gerber NU; Grotzer M; Benesch M; Schlegel PG; Deinlein F; von Bueren AO; Friedrich C; Juhnke BO; Obrecht D; Fleischhack G; Kwiecien R; Faldum A; Kortmann RD; Kool M; Rutkowski S
J Clin Oncol; 2020 Jun; 38(18):2028-2040. PubMed ID: 32330099
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of pathologic characteristics and prognosis in different subtypes of adult medulloblastoma].
Zhao F; Zhang J; Wang X; Wang Z; Wang Y; Qu P; Luo L; Liu P
Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):169-72. PubMed ID: 24842015
[TBL] [Abstract][Full Text] [Related]
34. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience.
Atalar B; Ozsahin M; Call J; Napieralska A; Kamer S; Villa S; Erpolat P; Negretti L; Lassen-Ramshad Y; Onal C; Akyurek S; Ugurluer G; Baumert BG; Servagi-Vernat S; Miller RC; Ozyar E; Sio TT
Radiother Oncol; 2018 Apr; 127(1):96-102. PubMed ID: 29373196
[TBL] [Abstract][Full Text] [Related]
35. Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
[TBL] [Abstract][Full Text] [Related]
36. Clinical-MRI radiomics enables the prediction of preoperative cerebral spinal fluid dissemination in children with medulloblastoma.
Zheng H; Li J; Liu H; Wu C; Gui T; Liu M; Zhang Y; Duan S; Li Y; Wang D
World J Surg Oncol; 2021 Apr; 19(1):134. PubMed ID: 33888125
[TBL] [Abstract][Full Text] [Related]
37. Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype.
Keil VC; Warmuth-Metz M; Reh C; Enkirch SJ; Reinert C; Beier D; Jones DTW; Pietsch T; Schild HH; Hattingen E; Hau P
AJNR Am J Neuroradiol; 2017 Oct; 38(10):1892-1898. PubMed ID: 28798218
[TBL] [Abstract][Full Text] [Related]
38. Adult medulloblastoma: prognostic factors and patterns of relapse.
Chan AW; Tarbell NJ; Black PM; Louis DN; Frosch MP; Ancukiewicz M; Chapman P; Loeffler JS
Neurosurgery; 2000 Sep; 47(3):623-31; discussion 631-2. PubMed ID: 10981749
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of semantic MRI features on survival outcomes in molecularly subtyped medulloblastoma.
Dasgupta A; Gupta T; Maitre M; Kalra B; Chatterjee A; Krishnatry R; Goda JS; Shirsat N; Epari S; Sahay A; Janu A; Pungavkar S; Chinnaswamy G; Patil V; Moiyadi A; Shetty P; Jalali R
Strahlenther Onkol; 2022 Mar; 198(3):291-303. PubMed ID: 35059761
[TBL] [Abstract][Full Text] [Related]
40. Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.
Triscott J; Yip S; Johnston D; Michaud J; Rassekh SR; Hukin J; Dunn S; Dunham C
Pediatr Dev Pathol; 2021; 24(4):309-317. PubMed ID: 33749384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
